Ensuring patient safety starts with reliable detection. If you’re working with parenteral drugs, this report is a must-read for your quality control toolkit. 🔗 Get the full report at the PDA Bookstore . Option 2: Short & Actionable (Team Update/Newsletter)
Historically, the bacterial endotoxins test (BET), as described in USP <85> and EP 2.6.14, was considered robust. However, in the early 2000s, manufacturers began noticing a disturbing trend: Drug product samples that initially failed endotoxin testing (showing the presence of harmful LPS) would test negative after storage, only to become positive again during patient infusion. pda technical report 82 pdf
Includes 12 comprehensive case studies detailing various LER occurrences and solutions. Ensuring patient safety starts with reliable detection
Downloading the PDF is just the first step. Here is how to implement its recommendations: Downloading the PDF is just the first step
When searching for a professionals are usually looking for guidance on how to handle the following complex scenarios: